Searchable abstracts of presentations at key conferences in endocrinology

ea0095oc9.3 | Oral Communications 9 | BSPED2023

A National Survey on the care and management of Children and Young people with Type 2 Diabetes

Uday Suma , Anilkumar Anjitha , Clark Heather , Walker Anthony , Sachdev Pooja

Background: The National Paediatric Diabetes audit (NPDA) reports increasing number of children and young people with type 2 diabetes (CYP2D). CYP2D are less likely to receive all recommended health checks compared to those with type 1 diabetes (33% vs 59% respectively) and do not receive treatment for complications even when they are identified (T2D spotlight audit 2019/20). We assessed variation in care across different units against the national T2D guideli...

ea0095oc9.5 | Oral Communications 9 | BSPED2023

Impact of using hybrid closed loop system in a tertiary children’s hospital: a single centre experience

B. Kamaleldeen Eman , L Randell Tabitha , Sachdev Pooja

Background: Hybrid closed loop (HCL) insulin systems are associated with better glycaemic control and reduced hypoglycaemia risk. They represent the most advanced form of insulin delivery for people with type 1 diabetes mellitus (T1DM).Aim: The study aimed to evaluate effectiveness of 3 HCL systems in children and young people (CYP) with T1DM at Nottingham Children’s Hospital.Methods:<...

ea0095p5 | Adrenal 1 | BSPED2023

Retrospective review of patients with 21-hydroxylase deficiency (21OHD) Congenital adrenal hyperplasia (CAH) in a tertiary children’s hospital

Riches Katherine , Abey Rose , Denvir Louise , Law James , Sachdev Pooja

Background: The most common form (90%) of CAH is 21-hydroxylase deficiency (21OHD). Management is with hydrocortisone ±fludrocortisone replacement while minimising side effects of androgen excess. Our aim was to review our CAH cohort and describe their characteristics, treatment regimens and growth.Methods: Retrospective data on height, weight, BMI, bone age and biochemical profiles was collected on 26 patients with...

ea0095p41 | Gonadal, DSD and Reproduction 1 | BSPED2023

A retrospective analysis of clinical characteristics, testosterone therapy, and comorbidity screening for klinefelter syndrome: Insights from a UK tertiary centre over the last two decades

Jeevarathnam Dhivyalakshmi , Chandwani Manju , Dixit Abhijit , Sachdev Pooja

The European Academy of Andrology (EAA) recently published consensus guidelines aiming to standardize the care provided to patients with Klinefelter syndrome (KS) across different stages of development. In this retrospective cross-sectional study, we reviewed the clinical care provided to 76 KS patients at Nottingham University Hospitals between 2000 and 2020.Methods: Data regarding age at presentation (n=30 paediatric, adult 46...

ea0078OC7.2 | Oral Communications 7 | BSPED2021

Multi-centre service evaluation of presentation of newly diagnosed type 1 diabetes in children in the U.K. furing the COVID-19 pandemic

McLean Ross , Mitchell Rod , Sachdev Pooja , Conway Nicky , Liu Jo-Fen

Background: The COVID-19 pandemic led to major changes in the pattern of presentation to Emergency Departments. This prompted concern within Paediatrics that this altered behaviour could lead to delays in the diagnosis of life-threatening conditions such as type 1 diabetes. A multicentre study was conducted to determine the incidence, referral patterns and severity of disease at presentation of this condition. Methods: This was a U.K.-based multi-centre ...

ea0051p050 | Pituitary and growth | BSPED2017

Siblings with 3-M Syndrome show good response to Growth Hormone (GH) therapy over a 4 year follow-up growth data

Mohamed Zainaba , Sachdev Pooja , Benson Joanna , Hastings Richard , Randell Tabitha , Denvir Louise

Introduction: 3M syndrome is a rare autosomal recessive condition that causes short stature, unusual facial features and skeletal abnormalities with normal intelligence. Mutations in CUL7, OBSL1 and CCDC8 genes have been identified as pathogenic. GH treatment outcomes for 3M syndrome appear controversial. Use of human recombinant GH for the treatment of short stature has been trialled in previous studies with some suggesting dysregulation in GH/IGF1 axis while others report no...

ea0051p069 | Diabetes | BSPED2017

A review of patients not carbohydrate counting in a Paediatric Diabetes Clinic

Briggs Rebecca , Denvir Louise , Randell Tabitha , Keeton Rachel , Sachdev Pooja , Calvert Jennifer

Background: NICE recommendation is to use multiple daily insulin injections and to offer level 3 carbohydrate-counting education at diagnosis of Type 1 diabetes (T1DM), and at least at annual intervals thereafter. Best Practice Tariff states that every young person with diabetes should be offered at least one additional appointment per year with a paediatric dietitian with training in diabetes. Our aim was to identify details of all the patients in the current cohort who were ...

ea0051p092 | Diabetes | BSPED2017

Description of the prevalence, demographics and service provision for children with autism or epilepsy in our type 1 diabetes clinic

Smith Chloe , Moran Maria , Ball Amy , Drew Josephine , Denvir Louise , Randell Tabitha , Sachdev Pooja

Background: Previous reports suggest that epilepsy and autism are more common in children with autoimmune diseases such as type 1 diabetes (T1D). While each condition is common in the general population, only small numbers of children have the two conditions together, so there is currently little coordinated support. We sought to describe the incidence in our own population.Methods: Retrospective review of the Diamond database and clinical notes for chil...

ea0085p10 | Bone | BSPED2022

Hypophosphatemic rickets as a key presenting feature of tyrosinemia type 1

Chandwani Manju , Usman Shehla , Law James , Denvir Louise , Sachdev Pooja , Randell Tabitha , Qureshi Isaque

Queen’s Medical Centre, Nottingham, United KingdomTyrosinemia type-1 is a rare autosomal recessive disorder. It usually presents in an acute form in early infancy. Rarely, it can also present as a chronic form with gradual onset. The key presenting features are failure to thrive, liver dysfunction and/or Fanconi syndrome. We present a perplexing case of a 2-year-old girl with tyrosinemia type-1, who initially presented with failure to thrive and hypophosphatemic rickets w...

ea0066oc8.3 | Oral Communications 8 | BSPED2019

Specially identified patients (SIPs) – how do they work?

Rajyaguru Vipul , Tan Shin , Law James , Sachdev Pooja , Denvir Louise , Randell Tabitha

Introduction: Children with adrenal insufficiency require emergency hydrocortisone for serious illness in addition to any regular requirements. Individualised emergency plans for patients during sick days, detailing their oral and intramuscular hydrocortisone requirements, should be maintained, alongside appropriate alerts on hospital and pre-hospital systems to ensure health professionals are aware of their requirements promptly if they present acutely unwell. Following a chi...